DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie


Appau KA, Fazio VW, Shen B. et al
Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn’s patients. 
Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 2008; 12: 1738-1744  

Download Bibliographical Data

Search in: